Navigation Links
CPhI 2009: Madrid Launch for BioPh Marks Pharma and Biotech Convergence
Date:10/7/2009

MAARSSEN, The Netherlands, Oct. 7 /PRNewswire/ -- CPhI Worldwide and connected events - the global pharma ingredients and services community's largest annual meeting - returns to Madrid on 12 - 15 October for its 20th staging.

The co-located ICSE contract services and P-MEC equipment and technology events are joined for 2009 under the Where Pharma Meets banner by the new, biotech-focused BioPh. The new platform markedly reflects the notable convergence of the pharma and biotech business models since Madrid first hosted CPhI in 2005.

Across the four events at Feria de Madrid, organisers UBM International Media expect a combined total approaching 1,700 exhibitors. First-time exhibitor bookings are 8% ahead of 2008. Significantly, CEO-level visitor pre-registrations are also up on last year.

One of several new features for 2009 is the all-new Pre-Show Seminar series on Monday 12 October, setting event context through the valuable insights of opinion leaders over a range of key sectors and topics.

Similarly, and returning after 2008's highly successful launch, the Tuesday and Wednesday morning Breakfast Briefings team the European Fine Chemicals Group (EFCG) and Euromonitor International with the CPhI Conferences group to focus on industry-critical issues.

The year's standout development - and the second event launched in Madrid after P-MEC in 2005 - is the debut of BioPh, Bio-solutions for Pharma.

BioPh marks the convergence of pharma and biotech business models in global healthcare - and the increasing bio-pharma partnerships in drug innovation, production and market delivery. The new exhibition is a timely link between the biotech innovation that increasingly drives pharma and the proven networking platform of CPhI for ingredients and production interests.

Within BioPh, UBM is teaming with PCM - Parque Scientifico de Madrid, a member of Enterprise Europe Network (EEN) - to offer a pharma and biotechnology "partnering" brokerage event at Feria de Madrid on Wednesday 14 October. (Stand 10A56)

Other highlights this year include the sixth staging of the annual CPhI Innovation Awards and the return of the popular Speakers' Corner within both CPhI and ICSE.

UBM Pharma Portfolio Group Director Eliane van Doorn commented: "New event features this year reflect ongoing industry changes and the expanding role of healthcare biotechnology since CPhI's first Madrid visit in 2005.

"They also mark our determination to add interest and value year-on-year for established and new audiences alike - building business value across events, conferences, networking opportunities and online."

Regarding the business outlook she continued: "We expect the long run of year-over-year growth in visitor numbers for CPhI Worldwide to be interrupted for 2009. However, after the tough global business conditions since late 2008, we are now seeing more positive forecasts. There are better indicators for the global economy and also that the key emerging pharma markets of China, India and Russia will see returns to double-digit growth."

For 2010, the Europe events are timed a week earlier, when the CPhI family will return to Paris-Nord Villepinte, on Tuesday 5 - Thursday 7 October. Paris last hosted the events in 2006.

Worldwide locations of annual sister events for the pharma sector hosted by UBM include Japan (April); China (June); South America - Argentina (August 2010) and India (November).See: www.wherepharmameets.com; www.cphi.com; www.icsexpo.com; www.bioph-online.com and www.p-mec.com.

SOURCE CPhI Worldwide


'/>"/>
SOURCE CPhI Worldwide
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
4. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
5. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
6. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
7. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
8. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
9. Premier Micronutrient Launches Supplement for Hearing Health
10. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
11. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 ... ... Company, Cal Dining at the University of California Berkeley, and other leading institutions ... leverages the buying power of institutions to change the way animals are raised ...
Breaking Medicine News(10 mins):